Filing Flows

Filing Flows › Scientist Home Future Health (SHFH) › Q1 2026

Scientist Home Future Health (SHFH) Q1 2026 earnings results (first quarter 2026)

10-Q filed May 14, 2026

Scientist Home Future Health (SHFH) reported revenue of $189K for the first quarter 2026 (Q1 2026), +321% from a year earlier and +114% from the quarter before. Operating margin was -54.1%, net loss $102K (54.1% of revenue).

Revenue$189K
Year over year+321%
Quarter over quarter+114%
Operating margin-54.1%
Net earnings−$102K

Scientist Home Future Health, Q1 2026: revenue $189K (+321% year over year), operating margin -54.1%, net loss $102K, operating cash flow −$72K. The chart follows the revenue to costs, profit and cash.

Q1 2026AmountQ/QY/Y
Revenue$189K+114%+321%
Operating profit−$102K—-1559%
Net earnings−$102K—-1785%
Operating cash flow−$72K——

What changed

Revenue was $189K in Q1 2026, up 321% year over year and up 114% from the previous quarter. Retail Trading Business was the largest line at 97% of revenue. Retail Trading Business added $137K year over year (up 307%), 95% of the total change.

Gross margin was 31.3%, down 12.6 points from Q1 2025. Operating costs exceeded revenue by $102K, an operating margin of -54.1%. Operating expenses grew 1169% against revenue growth of 321%. The quarter ended with a net loss of $102K, narrower than the previous quarter's $153K loss.

Operating cash flow was −$72K. Non-cash charges added back $4K of depreciation. Working capital and other items added $27K. Capital expenditures of $69K exceeded it, leaving free cash flow of −$141K.

Questions

What was Scientist Home Future Health's revenue in the first quarter 2026?

Scientist Home Future Health (SHFH) reported revenue of $189K for the first quarter 2026 (Q1 2026), +321% from a year earlier and +114% from the quarter before.

Was Scientist Home Future Health profitable in the first quarter 2026?

Operating loss was $102K (-54.1% of revenue) and net loss $102K.

Open the interactive Sankey →

Source: Scientist Home Future Health 10-Q on SEC EDGAR.